Repeat stereotactic radiosurgery for persistent cerebral arteriovenous malformations in pediatric patients

OBJECTIVE The purpose of this study was to describe the long-term outcomes and associated risks related to repeat stereotactic radiosurgery (SRS) for persistent arteriovenous malformations (AVMs) in pediatric patients.

METHODS Under the auspices of the International Radiosurgery Research Foundation, this retrospective multicenter study analyzed pediatric patients who underwent repeat, single-session SRS between 1987 and 2022. The primary outcome variable was a favorable outcome, defined as nidus obliteration without hemorrhage or neurological deterioration. Secondary outcomes included rates and probabilities of hemorrhage, radiation-induced changes (RICs), and cyst or tumor formation.

RESULTS The cohort included 83 pediatric patients. The median patient age was 11 years at initial SRS and 15 years at repeat SRS. Fifty-seven children (68.7%) were managed exclusively using SRS, and 42 (50.6%) experienced hemorrhage prior to SRS. Median AVM diameter and volume were substantially different between the first (25 mm and 4.5 cm3, respectively) and second (16.5 mm and 1.6 cm3, respectively) SRS, while prescription dose and isodose line remained similar. At the 5-year follow-up evaluation from the second SRS, nidus obliteration was achieved in 42 patients (50.6%), with favorable outcome in 37 (44.6%). The median time to nidus obliteration and hemorrhage was 35.5 and 38.5 months, respectively. The yearly cumulative probability of favorable outcome increased from 2.5% (95% CI 0.5%–7.8%) at 1 year to 44% (95% CI 32%–55%) at 5 years. The probability of achieving obliteration followed a similar pattern and reached 51% (95% CI 38%–62%) at 5 years. The 5-year risk of hemorrhage during the latency period after the second SRS reached 8% (95% CI 3.2%–16%). Radiographically, 25 children (30.1%) had RICs, but only 5 (6%) were symptomatic. Delayed cyst formation occurred in 7.2% of patients, with a median onset of 47 months. No radiation-induced neoplasia was observed.

CONCLUSIONS The study results showed nidus obliteration in most pediatric patients who underwent repeat SRS for persistent AVMs. The risks of symptomatic RICs and latency period hemorrhage were quite low. These findings suggest that repeat radiosurgery should be considered when treating pediatric patients with residual AVM after prior SRS. Further study is needed to define the role of repeat SRS more fully in this population.

Files

Metadata

Work Title Repeat stereotactic radiosurgery for persistent cerebral arteriovenous malformations in pediatric patients
Access
Open Access
Creators
  1. Gracie Garcia
  2. Georgios Mantziaris
  3. Stylianos Pikis
  4. Chloe Dumot
  5. L. Dade Lunsford
  6. Ajay Niranjan
  7. Zhishuo Wei
  8. Priyanka Srinivasan
  9. Lilly W. Tang
  10. Roman Liscak
  11. Jaromir May
  12. Cheng Chia Lee
  13. Huai Che Yang
  14. Selcuk Peker
  15. Yavuz Samanci
  16. Ahmed M. Nabeel
  17. Wael A. Reda
  18. Sameh R. Tawadros
  19. Khaled Abdel Karim
  20. Amr M.N. El-Shehaby
  21. Reem Emad Eldin
  22. Ahmed Hesham Elazzazi
  23. Nuria Martínez Moreno
  24. Roberto Martínez Álvarez
  25. Varun Padmanaban
  26. Francis J. Jareczek
  27. James McInerney
  28. Kevin M. Cockroft
  29. Juan Diego Alzate
  30. Douglas Kondziolka
  31. Manjul Tripathi
  32. Jason P. Sheehan
Keyword
  1. Arteriovenous malformation
  2. Stereotactic radiosurgery
  3. Vascular disorders
License In Copyright (Rights Reserved)
Work Type Article
Publisher
  1. Journal of Neurosurgery: Pediatrics
Publication Date January 26, 2024
Publisher Identifier (DOI)
  1. https://doi.org/10.3171/2023.12.PEDS23465
Deposited March 04, 2025

Versions

Analytics

Collections

This resource is currently not in any collection.

Work History

Version 1
published

  • Created
  • Added RepeatSRS_pedsAVM.pdf
  • Added Creator Gracie Garcia
  • Added Creator Georgios Mantziaris
  • Added Creator Stylianos Pikis
  • Added Creator Chloe Dumot
  • Added Creator L. Dade Lunsford
  • Added Creator Ajay Niranjan
  • Added Creator Zhishuo Wei
  • Added Creator Priyanka Srinivasan
  • Added Creator Lilly W. Tang
  • Added Creator Roman Liscak
  • Added Creator Jaromir May
  • Added Creator Cheng Chia Lee
  • Added Creator Huai Che Yang
  • Added Creator Selcuk Peker
  • Added Creator Yavuz Samanci
  • Added Creator Ahmed M. Nabeel
  • Added Creator Wael A. Reda
  • Added Creator Sameh R. Tawadros
  • Added Creator Khaled Abdel Karim
  • Added Creator Amr M.N. El-Shehaby
  • Added Creator Reem Emad Eldin
  • Added Creator Ahmed Hesham Elazzazi
  • Added Creator Nuria Martínez Moreno
  • Added Creator Roberto Martínez Álvarez
  • Added Creator Varun Padmanaban
  • Added Creator Francis J. Jareczek
  • Added Creator James McInerney
  • Added Creator Kevin M. Cockroft
  • Added Creator Juan Diego Alzate
  • Added Creator Douglas Kondziolka
  • Added Creator Manjul Tripathi
  • Added Creator Jason P. Sheehan
  • Published
  • Updated
  • Updated Keyword, Description, Publication Date Show Changes
    Keyword
    • Arteriovenous malformation, Stereotactic radiosurgery, Vascular disorders
    Description
    • OBJECTIVE The purpose of this study was to describe the long-term outcomes and associated risks related to repeat stereotactic radiosurgery (SRS) for persistent arteriovenous malformations (AVMs) in pediatric patients. METHODS Under the auspices of the International Radiosurgery Research Foundation, this retrospective multicenter study analyzed pediatric patients who underwent repeat, single-session SRS between 1987 and 2022. The primary outcome variable was a favorable outcome, defined as nidus obliteration without hemorrhage or neurological deterioration. Secondary outcomes included rates and probabilities of hemorrhage, radiation-induced changes (RICs), and cyst or tumor formation. RESULTS The cohort included 83 pediatric patients. The median patient age was 11 years at initial SRS and 15 years at repeat SRS. Fifty-seven children (68.7%) were managed exclusively using SRS, and 42 (50.6%) experienced hemorrhage prior to SRS. Median AVM diameter and volume were substantially different between the first (25 mm and 4.5 cm<sup>3</sup>, respectively) and second (16.5 mm and 1.6 cm<sup>3</sup>, respectively) SRS, while prescription dose and isodose line remained similar. At the 5-year follow-up evaluation from the second SRS, nidus obliteration was achieved in 42 patients (50.6%), with favorable outcome in 37 (44.6%). The median time to nidus obliteration and hemorrhage was 35.5 and 38.5 months, respectively. The yearly cumulative probability of favorable outcome increased from 2.5% (95% CI 0.5%–7.8%) at 1 year to 44% (95% CI 32%–55%) at 5 years. The probability of achieving obliteration followed a similar pattern and reached 51% (95% CI 38%–62%) at 5 years. The 5-year risk of hemorrhage during the latency period after the second SRS reached 8% (95% CI 3.2%–16%). Radiographically, 25 children (30.1%) had RICs, but only 5 (6%) were symptomatic. Delayed cyst formation occurred in 7.2% of patients, with a median onset of 47 months. No radiation-induced neoplasia was observed. CONCLUSIONS The study results showed nidus obliteration in most pediatric patients who underwent repeat SRS for persistent AVMs. The risks of symptomatic RICs and latency period hemorrhage were quite low. These findings suggest that repeat radiosurgery should be considered when treating pediatric patients with residual AVM after prior SRS. Further study is needed to define the role of repeat SRS more fully in this population.
    • OBJECTIVE The purpose of this study was to describe the long-term outcomes and associated risks related to repeat stereotactic radiosurgery (SRS) for persistent arteriovenous malformations (AVMs) in pediatric patients.
    • METHODS Under the auspices of the International Radiosurgery Research Foundation, this retrospective multicenter study analyzed pediatric patients who underwent repeat, single-session SRS between 1987 and 2022. The primary outcome variable was a favorable outcome, defined as nidus obliteration without hemorrhage or neurological deterioration. Secondary outcomes included rates and probabilities of hemorrhage, radiation-induced changes (RICs), and cyst or tumor formation.
    • RESULTS The cohort included 83 pediatric patients. The median patient age was 11 years at initial SRS and 15 years at repeat SRS. Fifty-seven children (68.7%) were managed exclusively using SRS, and 42 (50.6%) experienced hemorrhage prior to SRS. Median AVM diameter and volume were substantially different between the first (25 mm and 4.5 cm<sup>3</sup>, respectively) and second (16.5 mm and 1.6 cm<sup>3</sup>, respectively) SRS, while prescription dose and isodose line remained similar. At the 5-year follow-up evaluation from the second SRS, nidus obliteration was achieved in 42 patients (50.6%), with favorable outcome in 37 (44.6%). The median time to nidus obliteration and hemorrhage was 35.5 and 38.5 months, respectively. The yearly cumulative probability of favorable outcome increased from 2.5% (95% CI 0.5%–7.8%) at 1 year to 44% (95% CI 32%–55%) at 5 years. The probability of achieving obliteration followed a similar pattern and reached 51% (95% CI 38%–62%) at 5 years. The 5-year risk of hemorrhage during the latency period after the second SRS reached 8% (95% CI 3.2%–16%). Radiographically, 25 children (30.1%) had RICs, but only 5 (6%) were symptomatic. Delayed cyst formation occurred in 7.2% of patients, with a median onset of 47 months. No radiation-induced neoplasia was observed.
    • CONCLUSIONS The study results showed nidus obliteration in most pediatric patients who underwent repeat SRS for persistent AVMs. The risks of symptomatic RICs and latency period hemorrhage were quite low. These findings suggest that repeat radiosurgery should be considered when treating pediatric patients with residual AVM after prior SRS. Further study is needed to define the role of repeat SRS more fully in this population.
    Publication Date
    • 2024-04-01
    • 2024-01-26